# A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors

> **NCT07077434** · PHASE1 · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 32 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** BMS-986504

## Key facts

- **NCT ID:** NCT07077434
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2027-01-19
- **Final completion:** 2027-01-19
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07077434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07077434, "A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07077434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*